CNY 4.77
(0.0%)
Year | EBITDA | EBITDA Growth |
---|---|---|
2023 | 1.12 Billion CNY | 11.46% |
2022 | 916.96 Million CNY | -69.14% |
2021 | 2.88 Billion CNY | 173.4% |
2020 | 1.23 Billion CNY | 13.13% |
2019 | 490.95 Million CNY | -14.13% |
2018 | 1.37 Billion CNY | 15.21% |
2017 | 1.17 Billion CNY | 22.73% |
2016 | 874 Million CNY | 0.35% |
2015 | 919 Million CNY | -8.13% |
2014 | 1.06 Billion CNY | 44.95% |
2013 | 711.03 Million CNY | 25.37% |
2012 | 534.26 Million CNY | 23.9% |
2011 | 370.69 Million CNY | 49.24% |
2010 | 320.47 Million CNY | 72.45% |
2009 | 175.79 Million CNY | 42.34% |
2008 | 181.85 Million CNY | -49.18% |
2007 | 253.77 Million CNY | 85.51% |
2006 | 139.31 Million CNY | 16.56% |
2005 | 119.79 Million CNY | 18.92% |
2004 | 100.92 Million CNY | 54.65% |
2003 | 64.98 Million CNY | -10.19% |
2002 | 72.36 Million CNY | 3.28% |
2001 | 70.06 Million CNY | 0.0% |
Year | EBITDA | EBITDA Growth |
---|---|---|
2024 Q2 | 223.73 Million CNY | -18.53% |
2024 Q1 | 289.09 Million CNY | 402.94% |
2024 Q3 | 169.85 Million CNY | -39.92% |
2023 Q3 | 183.8 Million CNY | -35.89% |
2023 Q4 | 68.99 Million CNY | -62.46% |
2023 Q1 | 426.43 Million CNY | 155.19% |
2023 FY | - CNY | 11.46% |
2023 Q2 | 286.69 Million CNY | -32.77% |
2022 Q1 | 301.6 Million CNY | -88.99% |
2022 FY | - CNY | -69.14% |
2022 Q2 | 201.81 Million CNY | -33.09% |
2022 Q3 | 209.64 Million CNY | 3.88% |
2022 Q4 | 167.1 Million CNY | -20.29% |
2021 Q1 | 250.7 Million CNY | 41.55% |
2021 Q3 | 314.38 Million CNY | 85.59% |
2021 Q4 | 2.73 Billion CNY | 771.22% |
2021 FY | - CNY | 173.4% |
2021 Q2 | 169.4 Million CNY | -32.43% |
2020 Q4 | 177.11 Million CNY | 34.74% |
2020 FY | - CNY | 13.13% |
2020 Q3 | 131.45 Million CNY | -73.11% |
2020 Q2 | 488.77 Million CNY | 56.41% |
2020 Q1 | 312.49 Million CNY | 332.3% |
2019 Q2 | 321.14 Million CNY | 16.4% |
2019 Q3 | 284.73 Million CNY | -11.34% |
2019 Q1 | 275.9 Million CNY | 69.2% |
2019 FY | - CNY | -14.13% |
2019 Q4 | 72.28 Million CNY | -74.61% |
2018 Q2 | 426.16 Million CNY | 53.83% |
2018 FY | - CNY | 15.21% |
2018 Q4 | 163.06 Million CNY | -47.6% |
2018 Q1 | 277.03 Million CNY | 34.07% |
2018 Q3 | 311.19 Million CNY | -26.98% |
2017 FY | - CNY | 22.73% |
2017 Q4 | 206.64 Million CNY | -24.4% |
2017 Q3 | 273.33 Million CNY | 10.07% |
2017 Q2 | 248.33 Million CNY | -5.73% |
2017 Q1 | 263.42 Million CNY | 96.44% |
2016 Q3 | 186.67 Million CNY | -16.71% |
2016 FY | - CNY | 0.35% |
2016 Q4 | 134.1 Million CNY | -28.16% |
2016 Q2 | 224.12 Million CNY | -5.86% |
2016 Q1 | 238.06 Million CNY | 64.92% |
2015 Q2 | 482.87 Million CNY | 166.56% |
2015 FY | - CNY | -8.13% |
2015 Q1 | 181.14 Million CNY | -60.33% |
2015 Q4 | 144.35 Million CNY | -29.52% |
2015 Q3 | 204.82 Million CNY | -57.58% |
2014 Q2 | 332.19 Million CNY | 220.67% |
2014 Q3 | 184.74 Million CNY | -44.39% |
2014 Q4 | 456.6 Million CNY | 147.15% |
2014 FY | - CNY | 44.95% |
2014 Q1 | 103.59 Million CNY | -70.25% |
2013 Q4 | 348.21 Million CNY | 363.63% |
2013 Q2 | 223.45 Million CNY | 130.06% |
2013 Q1 | 97.13 Million CNY | -63.98% |
2013 FY | - CNY | 25.37% |
2013 Q3 | 75.1 Million CNY | -66.39% |
2012 FY | - CNY | 23.9% |
2012 Q1 | 67.87 Million CNY | -65.3% |
2012 Q4 | 269.67 Million CNY | 278.05% |
2012 Q3 | 71.33 Million CNY | -48.65% |
2012 Q2 | 138.92 Million CNY | 104.69% |
2011 Q3 | 65.06 Million CNY | -57.83% |
2011 Q2 | 154.26 Million CNY | 156.97% |
2011 Q1 | 60.03 Million CNY | -53.83% |
2011 FY | - CNY | 49.24% |
2011 Q4 | 195.59 Million CNY | 200.63% |
2010 Q2 | 44.04 Million CNY | 3.11% |
2010 Q1 | 42.71 Million CNY | -26.58% |
2010 FY | - CNY | 72.45% |
2010 Q4 | 130.02 Million CNY | 219.54% |
2010 Q3 | 40.69 Million CNY | -7.61% |
2009 Q3 | 28.66 Million CNY | 38.2% |
2009 Q2 | 20.74 Million CNY | -15.84% |
2009 Q1 | 24.64 Million CNY | -43.04% |
2009 FY | - CNY | 42.34% |
2009 Q4 | 58.17 Million CNY | 102.93% |
2008 Q3 | -10.9 Million CNY | -176.18% |
2008 Q4 | 43.27 Million CNY | 496.68% |
2008 FY | - CNY | -49.18% |
2008 Q1 | 39.19 Million CNY | -69.91% |
2008 Q2 | 14.31 Million CNY | -63.46% |
2007 Q2 | 14.17 Million CNY | -26.92% |
2007 Q1 | 19.39 Million CNY | -70.62% |
2007 FY | - CNY | 85.51% |
2007 Q3 | 23.59 Million CNY | 66.45% |
2007 Q4 | 130.25 Million CNY | 451.94% |
2006 Q1 | 30.79 Million CNY | -41.79% |
2006 Q2 | 24.9 Million CNY | -19.14% |
2006 Q3 | 23.97 Million CNY | -3.73% |
2006 Q4 | 66.02 Million CNY | 175.37% |
2006 FY | - CNY | 16.56% |
2005 Q1 | 25.89 Million CNY | -51.83% |
2005 Q4 | 52.91 Million CNY | 196.55% |
2005 Q3 | 17.84 Million CNY | -36.46% |
2005 FY | - CNY | 18.92% |
2005 Q2 | 28.08 Million CNY | 8.43% |
2004 FY | - CNY | 54.65% |
2004 Q1 | 15.47 Million CNY | -35.11% |
2004 Q2 | 12.32 Million CNY | -20.38% |
2004 Q3 | 18.23 Million CNY | 48.03% |
2004 Q4 | 53.76 Million CNY | 194.78% |
2003 Q4 | 23.84 Million CNY | 23.21% |
2003 Q3 | 19.35 Million CNY | 0.0% |
2003 FY | - CNY | -10.19% |
2002 FY | - CNY | 3.28% |
2001 FY | - CNY | 0.0% |
Name | EBITDA | EBITDA Difference |
---|---|---|
Jiangsu Hengrui Medicine Co., Ltd. | 5.54 Billion CNY | 79.632% |
Zhangzhou Pientzehuang Pharmaceutical., Ltd | 3.57 Billion CNY | 68.441% |
Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd. | 192.74 Million CNY | -485.458% |
Aurora Optoelectronics Co.,Ltd. | -509.76 Million CNY | 321.367% |
Hangzhou TianMuShan Pharmaceutical Enterprise Co.,Ltd | -14.11 Million CNY | 8096.553% |
NanJing Pharmaceutical Company Limited | 1.61 Billion CNY | 30.314% |
GuangYuYuan Chinese Herbal Medicine Co., Ltd. | 157.93 Million CNY | -614.481% |
Tonghua Dongbao Pharmaceutical Co., Ltd. | 1.55 Billion CNY | 27.522% |